GW&K Investment Management’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.8M	Buy	1,421,109 +114,431	+9%	+$1.45M	0.14%	229
2025 Q4	$21.7M	Buy	1,306,678 +162,348	+14%	+$2.32M	0.19%	196
2025 Q3	$13.5M	Buy	1,144,330 +95,858	+9%	+$989K	0.12%	240
2025 Q2	$10.1M	Sell	1,048,472 -55,836	-5%	-$309K	0.09%	249
2025 Q1	$6.92M	Buy	1,104,308 +1,503	+0.1%	+$9.13K	0.06%	265
2024 Q4	$8.96M	Sell	1,102,805 -23,278	-2%	-$288K	0.08%	263
2024 Q3	$20.4M	Buy	1,126,083 +525,640	+88%	+$7.35M	0.17%	201
2024 Q2	$6.18M	Buy	600,443 +32,417	+6%	+$334K	0.06%	270
2024 Q1	$6.03M	Buy	568,026 +6,536	+1%	+$55.5K	0.05%	269
2023 Q4	$5.13M	Sell	561,490 -15,960	-3%	-$138K	0.05%	266
2023 Q3	$5.99M	Sell	577,450 -14,938	-3%	-$205K	0.06%	260
2023 Q2	$8.48M	Sell	592,388 -6,460	-1%	-$74.5K	0.08%	241
2023 Q1	$4.28M	Buy	598,848 +4,691	+0.8%	+$41.2K	0.04%	276
2022 Q4	$6.67M	Buy	594,157 +998	+0.2%	+$10.3K	0.07%	242
2022 Q3	$6.57M	Buy	593,159 +99,709	+20%	+$950K	0.07%	214
2022 Q2	$4.17M	Buy	493,450 +13,808	+3%	+$142K	0.04%	246
2022 Q1	$6.53M	Buy	479,642 +96,090	+25%	+$1.55M	0.06%	233
2021 Q4	$7.54M	Buy	383,552 +158,629	+71%	+$3.73M	0.06%	231
2021 Q3	$7.22M	Sell	224,923 -4,495	-2%	-$149K	0.06%	232
2021 Q2	$7.77M	Buy	229,418 +29,900	+15%	+$1.07M	0.07%	236
2021 Q1	$7.49M	Buy	+199,518	New	+$8.35M	0.07%	233